Search the Newsreel

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion

Bitmine Immersion Technologies (BMNR) announced that its Ethereum (ETH) holdings have reached 5.81 million tokens, contributing to total crypto and cash holdings of $11.6 billion. The company also stated it has repurchased over 19 million shares since July 2026 and that its MAVAN platform …

Bitmine Immersion Technologies reports $11.6B crypto & cash holdings, 5.81M ETH and large buyback

Bitmine Immersion Technologies (BMNR) announced significant crypto and cash holdings totaling $11.6 billion, including 5.81 million ETH. The company also disclosed that it has repurchased 3.0 million common shares in the past week as part of a larger $4 billion buyback program. Additionally, a …

Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00

Canaccord Genuity raised Zimmer Biomet's (NYSE:ZBH) price target from $83.00 to $100.00 while maintaining a "hold" rating, suggesting a 3.59% upside. The medical equipment provider recently reported strong quarterly earnings, beating EPS estimates by $0.06 and achieving a 4.8% year-over-year revenue increase. Analysts, on …

MoonLake Immunotherapeutics (NASDAQ:MLTX) Releases Earnings Results, Beats Estimates By $0.08 EPS

MoonLake Immunotherapeutics (MLTX) deepens loss but ends H1 2026 with $537M cash and key Phase 3 wins

Persimmon upgraded as broker says the stock remains cheap despite earnings headwinds

Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Scinai Immunotherapeutics has appointed Eran Kuratz as Head of Supply Chain and Business Process Administration for its CDMO subsidiary, Scinai Biopharma Services. This appointment aims to strengthen operational infrastructure and support the integration and scaling of Scinai's expanded CDMO platform, which now includes two …

Royal Bank of Canada Reduces Stock Position in BitMine Immersion Technologies, Inc. $BMNR

ImmuPharma, ValiRx, Tertiary Minerals, Caledonia Mining, Sintana Energy - Small Cap Snapshot

ImmuPharma PLC (AIM:IMM, FRA:25I) has signed up Kymos Group as its bioanalytical partner for diabetes drug Kapiglucagon. That completes the outsourced team needed to file for human trials in the US. ValiRx PLC (AIM:VAL, FRA:EAJF) is set to get a second European patent for …

Shimmick (SHIM) Earnings Date and Reports 2026

Shimmick Q2 2026 Earnings Call Transcript

Shimmick Corporation announced strong Q2 2026 results with $107 million in revenue and a 12% gross margin, driven by strategic execution and portfolio optimization. The company reported a backlog of $991 million and reaffirmed its full-year 2026 adjusted EBITDA guidance of $15 million–$30 million, …

Immunovant Inc (IMVT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Immersion Corp (IMMR) Earnings Forecast: Future EPS & Revenue Growth Estimates

HC Wainwright Estimates Immuneering Q3 Earnings

Price to earnings forward of Zimmer Biomet Holdings, Inc. – BX:ZIM

The article presents the "Price to earnings forward" value for Zimmer Biomet Holdings, Inc. (BX:ZIM) on TradingView. It appears to be a financial data point for the company, indicating its valuation based on future earnings expectations. The page also includes various navigation and information …

Immunocore Holdings (IMCR) Posted Strong Earnings, Is The 49% Undervaluation Case Convincing?

Price to sales forward of Immunome, Inc. – NASDAQ:IMNM

This article displays the "Price to sales forward" metric for Immunome, Inc. (NASDAQ: IMNM) on TradingView. It presents financial data for the company, indicating the value, change, and percentage change for this specific financial ratio. The content is primarily a data point rather than …

Zimmer Biomet Q2 Earnings Call Highlights

Key Points Interested in Zimmer Biomet Holdings, Inc.? Here are five stocks we like better. Zimmer Biomet reported solid Q2 growth: Net sales rose 4.8% to $2.177 billion, driven by hips, specialty businesses and technology. Adjusted EPS was $2.07, while U.S. organic sales increased …

ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach

ImmunityBio (IBRX) is under investor scrutiny after receiving marketing authorization in the UAE for ANKTIVA, used for bladder cancer and lung cancer. While the stock has seen significant year-to-date gains, its current valuation reflects rich revenue multiples and ongoing losses. Analysts present mixed views, …

AC Immune SA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

AC Immune SA reported a significant earnings miss for its latest quarter, with revenues of CHF15m and EPS of CHF0.02 falling short of analyst expectations. Following these results, analysts have revised their forecasts, increasing revenue estimates for 2026 to CHF45.7m but also projecting higher …

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Zimmer Biomet Holdings, Inc. (ZBH) stock, including its current price, news, and historical data. It notes a recent downgrade by BTIG due to growth challenges and presents performance metrics against the S&P 500. The article …

The Manufacturers Life Insurance Company Has $2.61 Million Stock Holdings in BitMine Immersion Technologies, Inc. $BMNR

The Manufacturers Life Insurance Company significantly increased its stake in BitMine Immersion Technologies (BMNR) by 612.7% in the first quarter, now owning 132,063 shares valued at approximately $2.61 million. Despite some analysts lowering price targets, the consensus rating for BMNR remains "Moderate Buy" with …

Lyell Immunopharma earnings beat by $0.22, revenue fell short of estimates

Lyell Immunopharma (NASDAQ: LYEL) reported second-quarter earnings per share of $-1.920, exceeding analyst estimates by $0.22. However, the company's revenue of $4K fell short of the consensus estimate of $5.5K. Despite a 23.580% drop in its stock price over the last three months, Lyell …

BitMine Immersion Technologies Inc Revenue Breakdown – LSX:A411ZL

This article provides a revenue breakdown for BitMine Immersion Technologies Inc (LSX:A411ZL). In the last year, the company generated 5.22 million EUR, with the "Self-mining" segment contributing the most at 2.68 million EUR. The United States was the largest regional contributor, accounting for all …

Immunocore Holdings PLC (IMCR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Bitmine Immersion Technologies (BMNR) Rebounds As Valuation Debate Gets Harder To Ignore

Immunovant (NASDAQ:IMVT) Posts Quarterly Earnings Results, Misses Estimates By $0.12 EPS

Immunocore Holdings plc (IMCR) Stock Price, News, Quote & History

Immunocore Holdings plc (IMCR) stock information is provided, including its current price of $34.56, up 1.71% in after-hours trading. The company, headquartered in the UK, focuses on developing immunomodulating medicines for cancer, infectious diseases, and autoimmune conditions, with its lead product KIMMTRAK approved for …

SHIMMICK Q2 2026 Earnings Preview: Recent $SHIM Insider Trading, Hedge Fund Activity, and More

Why ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next

ImmunityBio (IBRX) saw its stock rise by 6.6% following its Q2 2026 results and the expanded UAE marketing authorization for its immunotherapy ANKTIVA, now covering bladder and lung cancer in 34 countries. Despite increased revenue, the company reported wider net losses, highlighting the challenge …

ImmuPharma plc Revenue Breakdown – LSE:IMM

Lyell Immunopharma (NASDAQ:LYEL) Posts Earnings Results, Beats Expectations By $0.10 EPS

ImmuCell Corp (ICCC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for ImmuCell Corp (ICCC), including future estimates for EPS and revenue growth. It presents current stock performance data, market capitalization, and indicates that the financial forecasts were updated on August 8, 2026. The content also lists peer comparisons …

BitMine Immersion Technologies (BMNR) Stock Trades Like A Bargain On Book Value

Bitmine 2030 Stock Price Prediction: Why Did BMNR Stock Price Fall? How High Will It Rise in the Future?

Bitmine Immersion Technologies (BMNR) has transitioned into a premier Ethereum treasury company, acting as a high-beta proxy for ETH. Despite a recent stock price fall due to mark-to-market accounting losses and a perceived "blockchain impasse," the company's strategy involves acquiring ETH and repurchasing shares …

Possible Signal As Lyell Immunopharma Insiders Sell US$527k In Stock